Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development

Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development

Lung cancer is the leading cause of cancer deaths in the United States and across the world. Immunotherapies, which activate tumor-infiltrating cytotoxic T lymphocytes, have demonstrated efficacy for the treatment of advanced-stage lung cancer. However, the potential for harnessing the immune system...

Full description

Bibliographic Details
Main Authors: Ranya Guennoun, Jennet Hojanazarova, Kathryn E. Trerice, Marjan Azin, Matthew T. McGoldrick, Erik B. Schiferle, Michael P. Stover, Shadmehr Demehri
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
thymic stromal lymphopoietin
lung cancer
Kras
CD4<sup>+</sup> T cell
antitumor immunity
Online Access:https://www.mdpi.com/2072-6694/14/9/2173

Internet

https://www.mdpi.com/2072-6694/14/9/2173

Similar Items